Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Cirrhosis
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Cirrhosis
    TopAbstracts in Cirrhosis 07/01/2008 - (DGNews)
    TopAbstracts in Cirrhosis 06/03/2008 - (DGNews)
    TopAbstracts in Cirrhosis 05/06/2008 - (DGNews)
    Sorafenib Safe in Patients With Unresectable Hepatocellular Carcinoma and Advanced Liver Cirrhosis: Presented at EASL - (DGDispatch)
    Peg-Interferon Improves Event-Free Survival Compared With Colchicine in Patients With Cirrhosis and Portal Hypertension: Presented at EASL - (DGDispatch)

    News archive

     Recent webcasts/CME

      Webcasts/CME archive

       Recent cases - Cirrhosis
        Tuberculous Peritonitis in a German Patient with Primary Biliary Cirrhosis: A Case Report
        Hematochezia in a Patient With Liver Cirrhosis
        Successful Outcome of a Pregnancy in Women with Advanced Cirrhosis Due to Hepatitis B Surface Antigenemia, Delta Super-Infection and Hepatitis C Co-Infection: A Case Report
        Phosphodiesterase 5 Inhibitors Lower Both Portal and Pulmonary Pressure in Portopulmonary Hypertension. A Case Report
        Invasive Pulmonary Aspergillosis in Patients with Decompensated Cirrhosis: Case Series

        Cases archive
          




        my personal edition > cirrhosis > news
        divider

          E-Mail this DGReview to a colleague

        DGReview


        Misoprostol Produces Consistent Nitrogen Sparing In Cirrhosis Patients

        A DGReview of :"Effects of long-term oral misoprostol administration on hepatic amino acid-nitrogen metabolism in patients with cirrhosis"
        Journal of Hepatology

        07/24/2002
        By Harvey McConnell


        A consistent nitrogen sparing mechanism has been found to be produced by misoprostol in patients with cirrhosis, and the effects are not mediated by hormone levels.

        The effects found in the study of long-term oral misoprostol administration on hepatic amino acid-nitrogen metabolism in patients with cirrhosis may prove to be beneficial in clinical hepatology, declares Dr. Giampaolo Bianchi and colleagues at the University of Bologna, Bologna, Italy. They say controlled trials are now needed to assess the effects found in their study.

        The clinicians point out that the acute infusion of a prostaglandin of E series 1 (PGE1) analogue produces nitrogen sparing among patients with cirrhosis. In order to test the effects of long-term oral PGE1 on hepatic and whole-body nitrogen metabolism, they enrolled 10 patients with advanced cirrhosis.

        The patients were studied in paired experiments before and 30-50 days after they had received oral misoprostol therapy.

        Alpha-amino-nitrogen levels and urea-nitrogen synthesis rate were measured in the post-absorption state, and in response to continuous alanine infusion at 2 mmol/kg per hour for 4.5 hours. The data obtained were used to compute the functional hepatic nitrogen clearance.

        Dr. Bianchi and colleagues found that misoprostol reduced urea-nitrogen synthesis rate, both during fasting and in response to alanine, and this resulted in a positive nitrogen exchange. There was a slight increase in functional hepatic nitrogen clearance, with the indication of a reduced urea synthesis rate at any alpha-amino-N concentration.

        There was no accumulation in plasma of either amino acid- and ammonia-N. In addition, the clinicians did not observe any systematic effects on insulin and glucagon.
        Journal of Hepatology, Vol. 37 (1) (2002) pp. 15-21. "Effects of long-term oral misoprostol administration on hepatic amino acid-nitrogen metabolism in patients with cirrhosis"

        E-Mail this DGReview to a colleague   To print, use this version






        All contents Copyright (c) 1995-2008 Doctor's Guide Publishing Limited. All rights reserved.



        The NTK initiative. Physicians helping physicians identify Need-To-Know science
           Feedback
        Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
        Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
        1
        2
        3
        4
        5
        6
        7
        Send